Investigation into classification/sourcing of suspect counterfeit Heptodin™ tablets by near infrared chemical imaging

被引:48
作者
Lopes, Marta B. [2 ]
Wolff, Jean-Claude [1 ]
机构
[1] GlaxoSmithKline, Med Res Ctr, Stevenage SG1 2NY, Herts, England
[2] Univ Tecn Lisboa, IST, Inst Biotechnol & Bioengn, P-1049001 Lisbon, Portugal
关键词
Counterfeit medicines; Near-infrared chemical imaging; Near-infrared spectroscopy; Principal component analysis; k-Means clustering; Classification of counterfeit medicines; DESORPTION ELECTROSPRAY-IONIZATION; TRAP MASS-SPECTROMETRY; PHARMACEUTICAL PRODUCTS; ANTIMALARIAL TABLETS; CONTENT UNIFORMITY; DOSAGE FORMS; SPECTROSCOPY; IDENTIFICATION;
D O I
10.1016/j.aca.2008.11.036
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
Near infrared chemical imaging (NIR-CI) analysis was performed on 55 counterfeit Heptodin (TM) tablets obtained from a market Survey and an additional 11 authentic Heptodin (TM) tablets for comparison. The aim of the study was to investigate whether NIR-CI can be used to detect the counterfeit tablets and to classify/source them so as to understand the possible number of origins to aid investigators and authorities to shut down counterfeiting operations. NIR-CI combined with multivariate analysis is particularly suited to compare chemical and physical properties of samples, since it is a quick and non-destructive method of analysis. Counterfeit tablets were easily distinguished from the authentic ones. Principal component analysis (PCA) and k-means clustering were performed on the data set. The results from both analyses grouped the Counterfeit tablets in 13 main groups. The main groups found with both methods were quite consistent. Out of the 55 tablets only 18% contained the correct active pharmaceutical ingredient (API). i.e., the anti-viral drug lamivudine. The remaining 82% of counterfeit tablets contained talc and starch as main excipients. The API containing tablets classified into three main groups, based mainly on the amount of lamivudine present in the tablet. The group which had close to the correct amount of lamivudine sub-classified into three groups. From the analysis carried out, it is likely that the counterfeit tablets originate from as many as 15 different sources. (C) 2008 Elsevier B.V. All rights reserved.
引用
收藏
页码:149 / 155
页数:7
相关论文
共 40 条
  • [1] Aldhous P, 2005, NATURE, V434, P132, DOI 10.1038/434132a
  • [2] [Anonymous], 1999, Tech. Rep
  • [3] [Anonymous], 2009, Multivariate Observations, DOI DOI 10.1002/9780470316641
  • [4] Quality evaluation of chloroquine, quinine, sulfadoxine-pyrimethamine and proguanil formulations sold on the market in East Congo DR
    Atemnkeng, M. A.
    Chimanuka, B.
    Plaizier-Vercammen, J.
    [J]. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2007, 32 (02) : 123 - 132
  • [5] CARRIER D, RAPID COMMUN M UNPUB
  • [6] Finding key impurities in different manufacturing routes of a drug substance using liquid chromatography/mass spectrometry followed by principal components analysis
    Carrier, Dan
    Eckers, Christine
    Arnoult, Tiffanie
    Thurston, Thomas
    Major, Hilary
    [J]. RAPID COMMUNICATIONS IN MASS SPECTROMETRY, 2007, 21 (23) : 3946 - 3948
  • [7] Extracting process-related information from pharmaceutical dosage forms using near infrared microscopy
    Clarke, F
    [J]. VIBRATIONAL SPECTROSCOPY, 2004, 34 (01) : 25 - 35
  • [8] Fast detection and identification of counterfeit antimalarial tablets by Raman spectroscopy
    de Veij, Marleen
    Vandenabeele, Peter
    Hall, Krystyn Alter
    Fernandez, Facundo M.
    Green, Michael D.
    White, Nicholas J.
    Dondorp, Arjen M.
    Newton, Paul N.
    Moens, Luc
    [J]. JOURNAL OF RAMAN SPECTROSCOPY, 2007, 38 (02) : 181 - 187
  • [9] Pharmaceutical counterfeiting
    Deisingh, AK
    [J]. ANALYST, 2005, 130 (03) : 271 - 279
  • [10] Dixon JS, 2000, ACTA GASTRO-ENT BELG, V63, P348